Enhanced CGM for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.
Who Is on the Research Team?
Jovan Milosavljevic, MD
Principal Investigator
Montefiore Medical Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Pre-implementation
Patients receive usual care under the direction of their primary care provider and practice
Implementation
Clinics transition from usual care to the SPARK-CGM intervention, including development of workflows, provider education, and staff training
Follow-up
Participants are monitored for CGM utilization, hospitalizations, ED visits, and glucose management indicators
What Are the Treatments Tested in This Trial?
Interventions
- SPARK-CGM
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Clinics will sequentially transition from the usual care (control) condition to the intervention phase at three-month intervals until all clusters receive the intervention. The active implementation phase at each cluster will span six months, providing sufficient time to equip clinics to use CGM. The intervention includes development of clinic workflows for CGM prescribing and onboarding, provider education on CGM use and interpretation, training of clinic staff to support CGM initiation, and regular performance feedback on CGM prescribing rates.
Patients in pre-implementation practices will receive the usual care under the direction of their primary care provider and practice.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
American Diabetes Association
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.